Achieve Life Sciences
ACHV
111 hedge funds and large institutions have $539M invested in Achieve Life Sciences in 2026 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 17 closing their positions.
2,085% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $844K
748% more capital invested
Capital invested by funds: $63.6M → $539M (+$475M)
182% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 17
157% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
39.95% more ownership
Funds ownership: 40.43% → 80.39% (+40%)
37% more funds holding
Funds holding: 81 → 111 (+30)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$36.3M |
| 2 |
TGA
TPG GP A
Fort Worth,
Texas
|
+$32.8M |
| 3 |
VP
venBio Partners
San Francisco,
California
|
+$28.2M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$25.9M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$23.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.17M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.91M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.68M |
| 4 |
Two Sigma Investments
New York
|
-$703K |
| 5 |
Jane Street
New York
|
-$602K |
ACHV Hedge Fund Activity: Q2 2026 in Review
111 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2026, worth a combined $539M — up 748% from $63.6M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new ACHV positions and 17 closed out — a net gain of 31 holders — while 36 added to existing stakes and 14 trimmed.
The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $36.3M. The largest seller was Millennium Management, exiting entirely with an estimated $3.17M sold.
- 111 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2026, up from 81 in Q1 2026.
- Funds reported $539M of Achieve Life Sciences stock for Q2 2026, up 748% quarter-over-quarter.
- 48 funds opened new Achieve Life Sciences positions in Q2 2026 and 17 closed out, a net change of +31 holders.
- The largest Achieve Life Sciences buyer in Q2 2026 was Frazier Life Sciences Management, an estimated $36.3M added.
- The largest Achieve Life Sciences seller in Q2 2026 was Millennium Management, an estimated $3.17M sold.
Based on aggregated 13F filings for Q2 2026.